Back to LYEL
GSK plc LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
4
Latest value
$14.8M
Q3 2026
Peak value
$46.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $46.6M |
| Q1 2026 | $30.3M |
| Q2 2026 | $21.3M |
| Q3 2026 | $14.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $14.8M | 1.51M | — | — |
| Q2 2026 | $21.3M | 1.51M | — | — |
| Q1 2026 | $30.3M | 1.51M | — | — |
| Q4 2025 | $46.6M | 1.51M | — | — |